Search
Careers
Contact us
Menu
Careers
Contact us
ABOUT INOTREM
COMPANY OVERVIEW
LEADERSHIP TEAM
BOARD OF DIRECTORS
ADVISORY BOARDS
THERAPEUTIC APPROACH
TREM-1 PATHWAY
PERSONALIZED MEDICINE
DRUG DEVELOPMENT
NANGIBOTIDE AND MONOCLONAL ANTIBODIES
PIPELINE
THERAPEUTIC AREAS
INVESTORS
NEWS
PRESS RELEASES
EVENTS
SCIENTIFIC PUBLICATIONS
Menu
ABOUT INOTREM
COMPANY OVERVIEW
LEADERSHIP TEAM
BOARD OF DIRECTORS
ADVISORY BOARDS
THERAPEUTIC APPROACH
TREM-1 PATHWAY
PERSONALIZED MEDICINE
DRUG DEVELOPMENT
NANGIBOTIDE AND MONOCLONAL ANTIBODIES
PIPELINE
THERAPEUTIC AREAS
INVESTORS
NEWS
PRESS RELEASES
EVENTS
SCIENTIFIC PUBLICATIONS
ABOUT INOTREM
COMPANY OVERVIEW
LEADERSHIP TEAM
BOARD OF DIRECTORS
ADVISORY BOARDS
THERAPEUTIC APPROACH
TREM-1 PATHWAY
PERSONALIZED MEDICINE
DRUG DEVELOPMENT
NANGIBOTIDE AND MONOCLONAL ANTIBODIES
PIPELINE
THERAPEUTIC AREAS
INVESTORS
NEWS
PRESS RELEASES
EVENTS
SCIENTIFIC PUBLICATIONS
CAREERS
CONTACT US
Menu
ABOUT INOTREM
COMPANY OVERVIEW
LEADERSHIP TEAM
BOARD OF DIRECTORS
ADVISORY BOARDS
THERAPEUTIC APPROACH
TREM-1 PATHWAY
PERSONALIZED MEDICINE
DRUG DEVELOPMENT
NANGIBOTIDE AND MONOCLONAL ANTIBODIES
PIPELINE
THERAPEUTIC AREAS
INVESTORS
NEWS
PRESS RELEASES
EVENTS
SCIENTIFIC PUBLICATIONS
CAREERS
CONTACT US
NEWS & EVENTS
Categories
EVENTS
PRESS RELEASES
Archives
January 2024
November 2023
June 2023
April 2023
March 2023
February 2023
January 2023
November 2022
October 2022
May 2022
April 2022
March 2022
January 2022
November 2021
July 2021
June 2021
March 2021
February 2021
December 2020
October 2020
September 2020
July 2020
June 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
February 2019
January 2019
September 2018
January 2018
November 2017
September 2017
September 2016
February 2014